← Devices & Neurotechnology
Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry
Pre-treatment tinnitus assessment cohort
Also known as: Before any intervention, Before non-invasive neuromodulation therapy
Institution-led study
Sponsor / Institution
Institution-led study
Program Type
Diagnostic
Modality
Clinical Assessment/Endpoint
Stage
Not applicable
Status
Completed
Target Gene
—
Route / Mode
Assessment only
Confidence
85%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
China
Population
adult, tinnitus
Trial IDs
1
Mechanism
Baseline assessment cohort used before six months of personalized non-invasive acoustic neuromodulation therapy for subjective tinnitus.
Indications
Notes
This generated record was a baseline/pre-intervention artifact from an observational tinnitus neuromodulation study. It is verified as a study cohort/assessment record, not as software, neurotech, or a commercial product.
Evidence & Sources
1 structured sourcesclinicaltrials
Supports: canonicalName, company, allCompanies, isIndustrySponsored, programType, modality, mechanism, indications...
IDs: NCT06727175
Key Events
2024-07-31
Clinical Trials (1)
Data Checks
institution-led-studyregistry-only-evidencebaseline-assessment-artifactdiagnostic-study-not-product
Related Programs
Lenire Tinnitus Treatment Device
Company: Neuromod Devices · Neuromodulation · Marketed
Auricle Tinnitus Device
Company: Auricle Inc. · Neuromodulation · Phase 2
Neuromonics Tinnitus Treatment System
Company: Neuromonics · Neuromodulation · Marketed
Tinearity G1 Tinnitus System
Company: Duearity · Neuromodulation · Marketed
Beltone Serene Hearing Aids
Company: Beltone · Hearing Aid/Software · Marketed
Signia Notch Therapy
Company: Signia · Neuromodulation · Marketed